Literature DB >> 61854

Conditioned EEG desynchronization and seizure occurrence in patients.

A R Wyler, J S Lockard, A A Ward, C A Finch.   

Abstract

Five patients with seizures poorly controlled by standard anticonvulsant medication, underwent EEG operant conditioning. The operant paradigm reinforced the production of low voltage fast activity while decreasing frequencies below 10 c/sec. Seizure frequency decreased in 2 patients, seizure severity was attenuated in 2 others, and one patient who was only given reinforecement for scalp EMG suppression whowed no change in seizure parameters. Pseudoconditioning and control periods ruled out placebo effects. A rationale for this phenomenon is proposed.

Entities:  

Mesh:

Year:  1976        PMID: 61854     DOI: 10.1016/0013-4694(76)90062-6

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  6 in total

Review 1.  Behavioural treatment of epilepsy.

Authors:  P B Fenwick
Journal:  Postgrad Med J       Date:  1990-05       Impact factor: 2.401

2.  Behavioral and electroencephalographic correlates of 40-Hz EEG biofeedback training in humans.

Authors:  B L Bird; F A Newton; D E Sheer; M Ford
Journal:  Biofeedback Self Regul       Date:  1978-03

3.  Biofeedback training of 40-Hz EEG in humans.

Authors:  B L Bird; F A Newton; D E Sheer; M Ford
Journal:  Biofeedback Self Regul       Date:  1978-03

4.  Epileptic seizure disorders. Developments in diagnosis and therapy.

Authors:  E Niedermeyer; W Froescher; R S Fisher
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

5.  Possible Mechanisms Underlying Neurological Post-COVID Symptoms and Neurofeedback as a Potential Therapy.

Authors:  Mária Orendáčová; Eugen Kvašňák
Journal:  Front Hum Neurosci       Date:  2022-03-31       Impact factor: 3.473

6.  Changes in EEG Brain Connectivity Caused by Short-Term BCI Neurofeedback-Rehabilitation Training: A Case Study.

Authors:  Youhao Wang; Jingjing Luo; Yuzhu Guo; Qiang Du; Qiying Cheng; Hongbo Wang
Journal:  Front Hum Neurosci       Date:  2021-06-24       Impact factor: 3.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.